Can-Fite BioPharma Ltd.CANFNYSE
LOADING
|||
EV to Sales: Discounted Valuation
Trending higher, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
9.83
↓ 73% below average
Average (9y)
35.76
Historical baseline
Range
High:149.95
Low:3.28
CAGR
-23.0%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 9.83 | +38.9% |
| 2023 | 7.08 | -59.7% |
| 2022 | 17.58 | -14.0% |
| 2021 | 20.45 | +20.6% |
| 2020 | 16.95 | +416.9% |
| 2019 | 3.28 | -38.9% |
| 2018 | 5.37 | -77.9% |
| 2017 | 24.24 | -83.8% |
| 2016 | 149.95 | +45.7% |
| 2015 | 102.88 | - |